Home » USA Broker Ratings » Viking Therapeutics – Consenus Indicates Potential 545.2% Upside

Viking Therapeutics – Consenus Indicates Potential 545.2% Upside

Viking Therapeutics with ticker code (VIVE) now have 1 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 4 and 4 and has a mean target at 4. Now with the previous closing price of 0.62 this would indicate that there is a potential upside of 545.2%. There is a 50 day moving average of 0.63 while the 200 day moving average is 1.58. The company has a market cap of $6m. Find out more information at: http://www.viveve.com

Viveve Medical designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical was founded in 2005 and is headquartered in Englewood, Colorado.

Join us on our new LinkedIn page

Follow us on LinkedIn